{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:40:19Z","timestamp":1788489619035,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009447","name":"Leukemia and Lymphoma Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.leukres.2023.107315","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:04:47Z","timestamp":1684361087000},"page":"107315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-5464","authenticated-orcid":false,"given":"Xun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Thisdelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Ernesto","family":"Fajardo-Despaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer B.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Dawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Versha","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107315_bib1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2023.107315_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2023.107315_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2023.107315_bib4","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2010-09-307249","article-title":"CCL3 (MIP-1\u03b1) plasma levels and the risk for disease progression in chronic lymphocytic leukemia","volume":"117","author":"Sivina","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V100.4.1215.h81602001215_1215_1219","article-title":"The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia","volume":"100","author":"Ferrajoli","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib7","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2011-03-342436","article-title":"Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia","volume":"118","author":"Yan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib8","article-title":"Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.leukres.2023.107315_bib9","article-title":"T Cells in chronic lymphocytic leukemia: a two-edged sword","volume":"11","author":"Vlachonikola","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2023.107315_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jleuko\/qiad006","article-title":"Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion","volume":"113","author":"Le Saos-Patrinos","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.leukres.2023.107315_bib11","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.177.1.213","article-title":"Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia","volume":"177","author":"Buschle","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2023.107315_bib13","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2016.151100","article-title":"T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers","volume":"102","author":"Palma","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107315_bib15","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.4049\/jimmunol.128.6.2563","article-title":"Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells","volume":"128","author":"Center","year":"1982","journal-title":"J. Immunol."},{"issue":"2000","key":"10.1016\/j.leukres.2023.107315_bib16","first-page":"2474","article-title":"B lymphocyte-derived IL-16 attracts dendritic cells and Th cells","volume":"165","author":"Kaser","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.leukres.2023.107315_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2567.2000.00959.x","article-title":"Human B-cell lines constitutively express and secrete interleukin-16","volume":"99","author":"Sharma","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2023.107315_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1074\/jbc.273.2.1144","article-title":"Processing and activation of pro-interleukin-16 by caspase-3","volume":"273","author":"Zhang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2023.107315_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1615\/CritRevImmunol.v28.i6.10","article-title":"lnterleukin-16: the ins and outs of regulating T-cell activation","volume":"28","author":"Cruikshank","year":"2008","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.leukres.2023.107315_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archotol.127.9.1120","article-title":"Immunohistological expression of interleukin 16 in human tonsils","volume":"127","author":"Kramer","year":"2001","journal-title":"Arch. Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.leukres.2023.107315_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcp.24441","article-title":"Regulation of cellular processes by interleukin-16 in homeostasis and cancer","volume":"229","author":"Richmond","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.leukres.2023.107315_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.leukres.2013.08.001","article-title":"Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway","volume":"38","author":"Lafarge","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2023.107315_bib23","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41375-018-0012-5","article-title":"Distinct roles for phosphoinositide 3-kinases gamma and delta in malignant B cell migration","volume":"32","author":"Ali","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107315_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jlb.67.6.757","article-title":"Interleukin-16","volume":"67","author":"Cruikshank","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.leukres.2023.107315_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djs257","article-title":"Role of interleukin 16 in multiple myeloma","volume":"104","author":"Atanackovic","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.leukres.2023.107315_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10875-010-9464-8","article-title":"Interleukin-16 as a marker of S\u00e9zary syndrome onset and stage","volume":"31","author":"Richmond","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.leukres.2023.107315_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002189","article-title":"Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia","volume":"9","author":"Bozorgmehr","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.leukres.2023.107315_bib29","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/cncr.31538","article-title":"Cells cytokines chemokines, and cancer stress: a biobehavioral study of patients with chronic lymphocytic leukemia","volume":"124","author":"Andersen","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2023.107315_bib30","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood-2007-08-110130","article-title":"Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis","volume":"111","author":"Sellick","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107315_bib31","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.onc.1209897","article-title":"Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells","volume":"26","author":"Pickering","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2023.107315_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106628","article-title":"Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines","volume":"109","author":"Ishdorj","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2023.107315_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/sji.12026","article-title":"Pro-IL-16 is associated with MHC class II-mediated negative regulation of mouse resting B cell activation through MAP kinases, NF-\u03baB and Skp2-dependent p27kip regulation","volume":"77","author":"Yang","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.leukres.2023.107315_bib34","first-page":"4965","article-title":"Cutting edge: IL-16\/CD4 preferentially induces Th1 cell migration: requirement of CCR5","volume":"171","author":"Lynch","year":"2003","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.leukres.2023.107315_bib35","first-page":"6439","article-title":"Preferential migration of T regulatory cells induced by IL-16","volume":"179","author":"McFadden","year":"2007","journal-title":"J. Immunol. Baltim. Md"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:26Z","timestamp":1758935006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623005805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":35,"alternative-id":["S0145212623005805"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107315","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107315"}}